Antiretroviral therapy coverage among pregnant women with HIV worldwide 2010-2022
In 2022, roughly 82 percent of pregnant and breastfeeding women living with HIV worldwide had received antiretroviral therapy against the disease. Compared to 2010, antiretroviral therapy coverage for HIV among this group of women has increased considerably. This statistic illustrates the share of pregnant and breastfeeding women living with HIV that received antiretroviral therapy worldwide from 2010 to 2022.